Aileen Stockburger Net Worth

Aileen Stockburger biography

Aileen Stockburger serves as Independent Director of the Company. Since February 2018, Ms. Stockburger has provided M&A consulting and advisory services through Aileen Stockburger LLC. Prior to that, from 1989 through January 2018, Ms. Stockburger held various positions in Johnson & Johnson, most recently as Vice President, Wordwide Business Development & Strategic Planning for the DePuy Synthes Group of Johnson & Johnson, and as a member of its Worldwide Board and Group Operating Committee, from 2010-2018. In that role, she oversaw the group’s merger and acquisition activities, including deal structuring, negotiations, contract design and review, and deal terms. Before joining Johnson & Johnson, Ms. Stockburger spent several years at PriceWaterhouseCoopers, and earned her CPA certification. She is also a Non-Executive Director of Next Science Limited (ASX: NXS), a medical technology company headquartered in Sydney, Australia, with a primary focus in the development and continued commercialization of its proprietary technology to reduce the impact of biofilm based infections in human health. Ms. Stockburger received her MBA and BS from The Wharton School, University of Pennsylvania. The Company believes that Ms. Stockburger is qualified as a Board member of the Company because of her extensive experience in strategizing, managing and closing sizable, complex worldwide mergers and acquisitions, licensing agreements and divestitures, as well as her expertise in business development, strategic planning and finance.

How old is Aileen Stockburger?

Aileen Stockburger is 57, she's been the Independent Director of Microbot Medical Inc since 2020. There are 5 older and 8 younger executives at Microbot Medical Inc. The oldest executive at Microbot Medical Inc is Prof. Moshe Shoham, 69, who is the Co-Founder, Scientific Director & Member of Scientific Advisory Board.

What's Aileen Stockburger's mailing address?

Aileen's mailing address filed with the SEC is C/O MICROBOT MEDICAL INC., 288 GROVE STREET, SUITE 388, BRAINTREE, MA, 02184.

Insiders trading at Microbot Medical Inc

Over the last 8 years, insiders at Microbot Medical Inc have traded over $5,894,432 worth of Microbot Medical Inc stock and bought 10,000 units worth $11,000 . The most active insiders traders include Yoseph Bornstein, Investment Management Ltd A..., and Moshe Shoham. On average, Microbot Medical Inc executives and independent directors trade stock every 37 days with the average trade being worth of $46,188. The most recent stock trade was executed by Yoseph Bornstein on 19 October 2020, trading 4,881 units of MBOT stock currently worth $38,755.

What does Microbot Medical Inc do?

microbot medical was founded with the vision of pioneering micro invasive surgery, transforming one of the biggest trends in healthcare - minimally invasive surgery (estimated to be close to $20b by 2015); the company will provide transformational micro invasive technologies with the accuracy of robots and automated instruments to assist physicians in targeting the disease site with exquisite precision. microbot will solve one of the largest unmet needs in the medical field, where morbidity as a result of surgery is more frequently due to trauma involved in gaining access to the area to perform the intended procedure rather than from the procedure itself. through its unique platforms, microbot will reach multiple surgical spaces, capitalizing on the fact that minimally invasive techniques have been applied to most of the surgical specialties. microbot’s virob platform is an autonomous advancing micro robot (aamr), less then 1mm in diameter, which has the ability to advance (forward/bac

Microbot Medical Inc executives and stock owners

Microbot Medical Inc executives and other stock owners filed with the SEC include:

• Harel Gadot,
  Chairman of the Board, President, Chief Executive Officer
• Harel Gadot,
  Co-Founder, Pres, CEO & Chairman
• Dr. Eyal Morag M.D.,
  Chief Medical Officer
• David Ben Naim,
  Chief Financial Officer
• David Ben Naim CPA, M.B.A.,
  Chief Financial Officer
• Tal Wenderow,
  Independent Director
• Aileen Stockburger,
  Independent Director
• Martin Madden,
  Independent Director
• Prattipati Laxminarain,
  Independent Director
• Scott Burell,
  Independent Director
• Yoseph Bornstein,
  Independent Director
• Eyal Morag,
  Chief Medical Officer
• Simon Sharon,
  Chief Technology Officer
• Dr. Eric C. Leuthardt,
  Scientific Director & Member of Scientific Advisory Board
• Dr. Simon Sharon MBA, MSc,
  GM, CTO & Chairman of Scientific Advisory Board
• Prof. Moshe Shoham,
  Co-Founder, Scientific Director & Member of Scientific Advisory Board
• Yoav Zvi Waizer,
  Director
• Leon Lewkowicz,
  10% owner
• Capital Anstalt Alpha,
  10% owner
• Moshe Shoham,
  Director
• Yehezkel Himelfarb,
  COO and General Manager
• Investment Management Ltd A...,
  10% owner
• Rachel Vaknin,
  Chief Financial Officer
• Juan Diaz Cartelle,
  Chief Medical Officer